Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New version entries were added: Revision v3.4.3 on 2026-03-10 and 2026-03-07. The previous Revision v3.4.2 was removed on 2026-03-03 and 2026-02-28.
    Difference
    0.1%
    Check dated 2026-03-11T12:58:59.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    New update dates (2026-03-03 and 2026-02-28) were added to the study record history, and older update dates (2026-02-24 and 2026-02-21) were removed.
    Difference
    0.1%
    Check dated 2026-03-04T09:24:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Updates posted on 2026-02-21 and 2026-02-24 were added, and updates dated 2026-02-14 and 2026-02-17 were removed.
    Difference
    0.1%
    Check dated 2026-02-25T08:37:32.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    New study record updates dated 2026-02-14 and 2026-02-17 were added; updates dated 2026-02-07 and 2026-02-10 were removed.
    Difference
    0.1%
    Check dated 2026-02-18T04:52:13.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Page updates include revision v3.4.2 with dates 2026-02-10 and 2026-02-07, and the earlier funding lapse notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:23:32.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page now includes a government funding lapse notice banner and an updated revision note (v3.4.1) with new dates 2026-02-03 and 2026-01-31; earlier dates 2026-01-27 and 2026-01-24 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:10:31.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.